STERIS (NYSE:STE) Stock Acquired Rep. April McClain Delaney

Key Points

Error: Response status code does not indicate success: 520 ().

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of STERIS plc NYSE: STE. In a filing disclosed on April 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in STERIS stock on March 16th.

Representative April McClain Delaney also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Entegris NASDAQ: ENTG on 3/31/2026.
• Purchased $1,001 - $15,000 in shares of Somnigroup International NYSE: SGI on 3/31/2026.
• Purchased $1,001 - $15,000 in shares of Rollins NYSE: ROL on 3/31/2026.
• Purchased $1,001 - $15,000 in shares of Tractor Supply NASDAQ: TSCO on 3/31/2026.
• Purchased $1,001 - $15,000 in shares of Nasdaq NASDAQ: NDAQ on 3/31/2026.
• Sold $1,001 - $15,000 in shares of Bio-Techne NASDAQ: TECH on 3/26/2026.
• Purchased $1,001 - $15,000 in shares of Packaging Corporation of America NYSE: PKG on 3/20/2026.
• Purchased $1,001 - $15,000 in shares of Nasdaq NASDAQ: NDAQ on 3/18/2026.
• Purchased $1,001 - $15,000 in shares of Packaging Corporation of America NYSE: PKG on 3/17/2026.
• Purchased $1,001 - $15,000 in shares of Somnigroup International NYSE: SGI on 3/16/2026.

STERIS Price Performance

Shares of STERIS stock opened at $224.82 on Thursday. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.48 and a quick ratio of 1.75. The business's 50 day simple moving average is $236.04 and its two-hundred day simple moving average is $247.16. The stock has a market capitalization of $22.05 billion, a P/E ratio of 31.36 and a beta of 1.07. STERIS plc has a one year low of $204.90 and a one year high of $269.44.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 EPS for the quarter, hitting analysts' consensus estimates of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.The firm's revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the company posted $2.32 EPS. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Analysts forecast that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Tuesday, February 17th were paid a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend was Tuesday, February 17th. STERIS's payout ratio is 35.15%.

Insider Buying and Selling at STERIS

In related news, Director Cynthia L. Feldmann sold 3,098 shares of STERIS stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $237.21, for a total transaction of $734,876.58. Following the sale, the director directly owned 705 shares in the company, valued at $167,233.05. The trade was a 81.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.07% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On STERIS

A number of large investors have recently made changes to their positions in STE. Trust Co. of Vermont boosted its position in shares of STERIS by 30.2% during the fourth quarter. Trust Co. of Vermont now owns 164 shares of the medical equipment provider's stock valued at $42,000 after purchasing an additional 38 shares in the last quarter. Bailard Inc. boosted its position in shares of STERIS by 3.5% during the fourth quarter. Bailard Inc. now owns 1,118 shares of the medical equipment provider's stock valued at $283,000 after purchasing an additional 38 shares in the last quarter. Magnolia Capital Advisors LLC boosted its position in shares of STERIS by 1.2% during the third quarter. Magnolia Capital Advisors LLC now owns 3,588 shares of the medical equipment provider's stock valued at $888,000 after purchasing an additional 41 shares in the last quarter. Colonial Trust Co SC boosted its position in shares of STERIS by 0.3% during the third quarter. Colonial Trust Co SC now owns 12,329 shares of the medical equipment provider's stock valued at $3,051,000 after purchasing an additional 42 shares in the last quarter. Finally, Geneos Wealth Management Inc. boosted its position in shares of STERIS by 34.9% during the second quarter. Geneos Wealth Management Inc. now owns 174 shares of the medical equipment provider's stock valued at $42,000 after purchasing an additional 45 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have commented on STE. Wall Street Zen cut STERIS from a "strong-buy" rating to a "buy" rating in a research note on Saturday, March 28th. Weiss Ratings reaffirmed a "buy (b)" rating on shares of STERIS in a research note on Friday, January 9th. Six investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $275.20.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland's 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland's 6th Congressional District. She declared candidacy for the 2026 election. April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor's degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

STERIS Company Profile

STERIS Corporation NYSE: STE is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.